| 1 |
Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome
Alexander A. Zimprich, Monika Grabowski, Friedrich Asmus et al. · Nature Genetics
|
27 Aug 2001 |
485 |
| 2 |
Validation of the Ten-Item Internet Gaming Disorder Test (IGDT-10) and evaluation of the nine DSM-5 Internet Gaming Disorder criteria
Orsolya Király, Pawel Sleczka, Halley M. Pontes et al. · Addictive Behaviors
Open access |
26 Nov 2015 |
431 |
| 3 |
Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease
Julien Bryois et al. · Nature Genetics
Open access320 authors |
27 Apr 2020 |
400 |
| 4 |
Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement
Bengt I. Eriksson, Lars C. Borris, O.E. Dahl et al. · Journal of Thrombosis and Haemostasis
Open access |
13 Dec 2005 |
303 |
| 5 |
Acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes
Susanne Rösner, Stefan Leucht, Philippe Lehert et al. · Journal of Psychopharmacology
Review |
22 Aug 2007 |
299 |
| 6 |
Population pharmacokinetics and pharmacodynamics of once and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement
Lars C. Borris, Ola Einar Dahl, Sylvia K. Haas et al. · Thrombosis and Haemostasis
|
2008 |
271 |
| 7 |
Misuse of Medicines in the European Union: A Systematic Review of the Literature
Alicia Casati, Roumen Sedefov, Tim Pfeiffer-Gerschel · European Addiction Research
ReviewOpen access |
2012 |
249 |
| 8 |
Defining Substance Use Disorders: Do We Really Need More Than Heavy Use?
Jürgen T. Rehm, Simon Marmet, Peter P. Anderson et al. · Alcohol and Alcoholism
Open access |
7 Aug 2013 |
245 |
| 9 |
Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery
Wolfgang Mueck, Bengt I. Eriksson, Kenneth Alan Bauer et al. · Clinical Pharmacokinetics
|
2008 |
243 |
| 10 |
Handbook of Implicit Cognition and Addiction
Gerhard Bühringer · Addiction
|
22 May 2007 |
235 |
| 11 |
Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology
Hans Gollwitzer · Journal of Antimicrobial Chemotherapy
Open access |
28 Jan 2003 |
215 |
| 12 |
Impact of Fatty Liver Disease on Health Care Utilization and Costs in a General Population: A 5-Year Observation
Sebastian Edgar Baumeister, Henry Völzke, Paul Marschall et al. · Gastroenterology
Open access |
9 Nov 2007 |
210 |
| 13 |
CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities
Robin J.M. Franklin, Mikael Simons · Neuron
Open access |
12 Oct 2022 |
190 |
| 14 |
Prevalence of and Potential Influencing Factors for Alcohol Dependence in Europe
Jürgen T. Rehm, Peter P. Anderson, Joe M. Barry et al. · European Addiction Research
Open access |
18 Oct 2014 |
187 |
| 15 |
Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study
Michael Soyka, Christina Zingg, Gabriele Koller et al. · The International Journal of Neuropsychopharmacology
Open access |
21 Jan 2008 |
186 |
| 16 |
What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention
Hans‐Ulrich Wïttchen, Silke Behrendt, Michael Höfler et al. · International Journal of Methods in Psychiatric Research
Open access |
2008 |
173 |
| 17 |
Substanzkonsum und substanzbezogene Störungen in Deutschland im Jahr 2012
Alexander Pabst, Ludwig Kraus, Elena Gomes de Matos et al. · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice
Open access |
2013 |
173 |
| 18 |
Group Psychotherapy of Dysfunctional Fear of Progression in Patients with Chronic Arthritis or Cancer
Peter Herschbach, Petra Berg, Sabine Waadt et al. · Psychotherapy and Psychosomatics
|
4 Nov 2009 |
162 |
| 19 |
Non‐medical use of prescription opioids and prescription opioid‐related harms: why so markedly higher in N orth A merica compared to the rest of the world?
Benedikt Fischer, Annette Keates, Gerhard Bühringer et al. · Addiction
|
20 May 2013 |
148 |
| 20 |
O-(2-[18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes
Friederike C. Rau, Wolfgang Weber, Hans‐Jürgen Wester et al. · European Journal of Nuclear Medicine and Molecular Imaging
|
28 May 2002 |
142 |
| 21 |
Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits
Eva Hoch, Nora D. Volkow, Chris M. Friemel et al. · European Archives of Psychiatry and Clinical Neuroscience
Open access |
19 Sep 2024 |
132 |
| 22 |
The Use of Alcohol, Tobacco, Illegal Drugs and Medicines
Josefine Atzendorf, Christian Rauschert, Nicki‐Nils Seitz et al. · Deutsches Ärzteblatt international
Open access |
26 Aug 2019 |
132 |
| 23 |
Polychrome labeling of bone with seven different fluorochromes: Enhancing fluorochrome discrimination by spectral image analysis
Christoph Pautke, Stephan Vogt, Thomas Tischer et al. · Bone
|
20 Jul 2005 |
126 |
| 24 |
Antimetastatic Activity of a Novel Mechanism-Based Gelatinase Inhibitor
Achim Krüger, Matthias Arlt, Michael Gerg et al. · Cancer Research
|
May 2005 |
125 |
| 25 |
Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents
Stéphane Legleye, Daniela Piontek, Ludwig Kraus · Drug and Alcohol Dependence
|
24 Sep 2010 |
124 |
| 26 |
Combined Reporter Gene PET and Iron Oxide MRI for Monitoring Survival and Localization of Transplanted Cells in the Rat Heart
Takahiro Higuchi, Martina Anton, Katja Dumler et al. · Journal of Nuclear Medicine
Open access |
12 Jun 2009 |
122 |
| 27 |
Short scales to assess cannabis-related problems: a review of psychometric properties
Daniela Piontek, Ludwig Kraus, Danica Klempová · Substance Abuse Treatment Prevention and Policy
Open access |
Dec 2008 |
122 |
| 28 |
Estimating prevalence of problem drug use at national level in countries of the European Union and Norway
Ludwig Kraus, Rita Augustin, Martin Frischer et al. · Addiction
|
25 Mar 2003 |
122 |
| 29 |
Why are young people drinking less than earlier? Identifying and specifying social mechanisms with a pragmatist approach
Jukka Törrönen, Filip Roumeliotis, Eva Samuelsson et al. · International Journal of Drug Policy
Open access |
10 Dec 2018 |
118 |
| 30 |
Second generation of meniscus transplantation: in-vivo study with tissue engineered meniscus replacement
Vladimir Martinek, Peter Ueblacker, Katharina Braun et al. · Archives of Orthopaedic and Trauma Surgery
|
7 Oct 2005 |
113 |
| 31 |
Long waves of consumption or a unique social generation? Exploring recent declines in youth drinking
Ludwig Kraus, Robin Room, Michael Livingston et al. · Addiction Research & Theory
|
7 Jul 2019 |
110 |
| 32 |
The urokinase plasminogen activator system as a novel target for tumour therapy
Manfred Schmitt, Olaf G. Wilhelm, Ute Reuning et al. · Fibrinolysis and Proteolysis
|
Mar 2000 |
108 |
| 33 |
Prevalence of youth gambling and potential influence of substance use and other risk factors throughout 33 European countries: first results from the 2015 ESPAD study
Sabrina Molinaro, Elisa Benedetti, Marco Scalese et al. · Addiction
|
28 May 2018 |
102 |
| 34 |
Problematic drug use and drug use disorders in EU countries and Norway: An overview of the epidemiology
Jürgen Rehm, Robin Room, Wim van den Brinkt et al. · European Neuropsychopharmacology
|
14 Jun 2005 |
100 |
| 35 |
Why Do Young People Start Drinking? Motives for First-Time Alcohol Consumption and Links to Risky Drinking in Early Adolescence
Emmanuel N. Kuntsche, Stefanie Müller · European Addiction Research
|
3 Dec 2011 |
99 |
| 36 |
Defining key concepts for mental state attribution
François Quesque et al. · Communications Psychology
Open access |
11 Apr 2024 |
96 |
| 37 |
Patient goals in post-acute geriatric rehabilitation - goal attainment is an indicator for improved functioning
Eva Grill, Sandra Kus, M M uuml ller et al. · Journal of Rehabilitation Medicine
Open access |
2011 |
91 |
| 38 |
Measuring alcohol consumption and alcohol‐related problems: comparison of responses from self‐administered questionnaires and telephone interviews
Ludwig Kraus, Rita Augustin · Addiction
|
Mar 2001 |
88 |
| 39 |
Awareness of alcohol as a risk factor for cancer is associated with public support for alcohol policies
Sarah E. Bates, John Holmes, Lucy Gavens et al. · BMC Public Health
Open access |
4 Jun 2018 |
84 |
| 40 |
Association of Average Daily Alcohol Consumption, Binge Drinking and Alcohol-Related Social Problems: Results from the German Epidemiological Surveys of Substance Abuse
Ludwig Kraus, Sebastian‐Edgar Baumeister, Alexander Pabst et al. · Alcohol and Alcoholism
|
15 Jan 2009 |
84 |
| 41 |
Age, Period and Cohort Effects on Time Trends in Alcohol Consumption in the Swedish Adult Population 1979–2011
Ludwig Kraus, Mimmi Eriksson Tinghög, Annette Lindell et al. · Alcohol and Alcoholism
|
5 Mar 2015 |
84 |
| 42 |
A test system for gas sensors
H.-E. Endres, Hildegard D. Jander, Wolfgang Göttler · Sensors and Actuators B Chemical
|
Feb 1995 |
83 |
| 43 |
Prevalence of alcohol use and the association between onset of use and alcohol‐related problems in a general population sample in Germany
Ludwig Kraus, Kim Bloomfield, Rita Augustin et al. · Addiction
|
Sep 2000 |
83 |
| 44 |
Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: A naturalistic study in 2694 patients
Hans‐Ulrich Wïttchen, Sabine M. Apelt, Michael Soyka et al. · Drug and Alcohol Dependence
Open access |
14 Mar 2008 |
83 |
| 45 |
A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain
Martin Frischer, Matthew Hickman, Ludwig Kraus et al. · Addiction
|
Oct 2001 |
82 |
| 46 |
Cognitive Functioning During Methadone and Buprenorphine Treatment
Michael Soyka, Martin Lieb, Sabine Kagerer et al. · Journal of Clinical Psychopharmacology
|
12 Nov 2008 |
81 |
| 47 |
CANDIS treatment program for cannabis use disorders: Findings from a randomized multi-site translational trial
Eva Hoch, Gerhard Bühringer, A Pixa et al. · Drug and Alcohol Dependence
|
8 Oct 2013 |
80 |
| 48 |
Trends in Substance Use and Related Disorders
Nicki‐Nils Seitz, Kirsten Lochbühler, Josefine Atzendorf et al. · Deutsches Ärzteblatt international
Open access |
26 Aug 2019 |
79 |
| 49 |
Experimental basis and first application of clinical lymph vessel transplantation of secondary lymphedema
R. G. H. Baumeister, Jürgen Scifert, Baldur Wiebecke et al. · World Journal of Surgery
|
May 1981 |
78 |
| 50 |
Why Is Per Capita Consumption Underestimated in Alcohol Surveys? Results from 39 Surveys in 23 European Countries
Carolin Kilian, Jakob Manthey, Charlotte Probst et al. · Alcohol and Alcoholism
Open access |
5 May 2020 |
77 |